Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Jul 2023 – 20 Aug 2026, limited by LIC MF Mid Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | LIC MF Mid Cap Fund | Nifty Midcap 150 |
|---|---|---|
| 31 Jul 2023 | ₹100.00 | ₹100.00 |
| 01 Nov 2023 | ₹102.19 | ₹102.86 |
| 02 Feb 2024 | ₹120.36 | ₹126.40 |
| 05 May 2024 | ₹131.19 | ₹133.72 |
| 06 Aug 2024 | ₹149.82 | ₹145.76 |
| 07 Nov 2024 | ₹152.76 | ₹149.89 |
| 08 Feb 2025 | ₹142.66 | ₹140.17 |
| 12 May 2025 | ₹143.25 | ₹143.79 |
| 13 Aug 2025 | ₹147.57 | ₹148.99 |
| 14 Nov 2025 | ₹153.01 | ₹157.93 |
| 15 Feb 2026 | ₹148.20 | ₹154.77 |
| 19 May 2026 | ₹150.30 | ₹158.24 |
| 20 Aug 2026 | ₹164.01 | ₹165.41 |
| Metric | LIC · Regular · IDCW NAV ₹29.69 Very High risk ★★★★☆ | Category median Mid Cap Fund · 33 funds |
|---|---|---|
| +8.62% | +4.36% | |
| +18.00% | +14.16% | |
| — | +13.38% | |
| — | +7.79% | |
| +17.58% | +9.71% | |
| +11.80% | — | |
| +18.00% | +11.96% | |
| — | +10.86% | |
| — | +9.43% | |
| Risk | ||
| 16.67% | 17.59% | |
| 0.69 | 0.44 | |
| 0.94 | 0.61 | |
| -21.92% | -47.34% | |
| Nifty Midcap 150 | — | |
| -0.05% | -3.13% | |
| 1.02 | 0.97 | |
| 100.4% | 91.4% | |
| 100.8% | 102.1% | |
| 2.87% | 2.04% | |
| ₹350.29Cr | ₹9,315Cr | |
| — | — | |
| None | — | |
| ₹200 | — | |
| ₹5.00K | — | |
| 37% | 41% | |
| Karan Doshi · 3.1y | — | |
| 31 Jul 2023 | — | |
| 65 | — | |
| 25.8% | — | |
| 3.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.